The parade of Massachusetts biotech startups seeking to go public continued Monday, when Cerulean Pharma Inc. registered with regulators to raise up to $75 million to bankroll clinical trials of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback